Impact of GLP-1 Drugs on Senior Living Too Early to Tell as Adoption Grows
GLP-1 drugs have minimal impact on senior living operations with low adoption rates.
ATI Advisory is a company in Burnaze's franchise knowledge graph, mentioned since 2022. 6 stories link here, each summarized from the original publisher.
GLP-1 drugs have minimal impact on senior living operations with low adoption rates.
Senior living operators face a disconnect between high-tech adoption goals and resident skepticism regarding the impact of AI on human-centric care and personal health outcomes.
A new CMS model is an opportunity for senior living operators to add revenue and improve their clinical capabilities, but it will take new infrastructure and partners.

This story is part of your SHN+ subscription The senior living industry has a real chance to differentiate itself against the concept of aging at home, not only through a different

Right at Home applauds Congress for proposing the Expanding Care in the Home Act, which would enable more services to take place safely in the home.
The study showed that 88% of respondents would be more likely to choose a Medicare Advantage plan that offers a larger number of personal care hours.